These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 10901702

  • 1. Pharmacokinetic profiles in rats after intravenous, oral, or dermal administration of dapsone.
    Helton DR, Osborne DW, Pierson SK, Buonarati MH, Bethem RA.
    Drug Metab Dispos; 2000 Aug; 28(8):925-9. PubMed ID: 10901702
    [Abstract] [Full Text] [Related]

  • 2. Hydroxypropyl-beta-cyclodextrin-flutamide inclusion complex. II. Oral and intravenous pharmacokinetics of flutamide in the rat.
    Zuo Z, Tam YK, Diakur J, Wiebe LI.
    J Pharm Pharm Sci; 2002 Aug; 5(3):292-8. PubMed ID: 12553899
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics of aminomethylpropanol in rats following oral and a novel dermal study design.
    Saghir SA, Clark AJ, McClymont EL, Staley JL.
    Food Chem Toxicol; 2008 Feb; 46(2):678-87. PubMed ID: 17961896
    [Abstract] [Full Text] [Related]

  • 4. Analytical determination and pharmacokinetics of robenacoxib in the dog.
    Jung M, Lees P, Seewald W, King JN.
    J Vet Pharmacol Ther; 2009 Feb; 32(1):41-8. PubMed ID: 19161454
    [Abstract] [Full Text] [Related]

  • 5. Intravenous pharmacokinetics, oral bioavailability and dose proportionality of ragaglitazar, a novel PPAR-dual activator in rats.
    Jagannath K, Chaluvadi MR, Mullangi R, Mamidi NV, Srinivas NR.
    Biopharm Drug Dispos; 2004 Oct; 25(7):323-8. PubMed ID: 15386480
    [Abstract] [Full Text] [Related]

  • 6. NTP technical report on the toxicity studies of p-tert-butylcatechol (CAS No. 98-29-3) administered in feed to F344/N rats and B6C3F1 mice.
    Dunnick J.
    Toxic Rep Ser; 2002 Nov; (70):5-51. PubMed ID: 12592414
    [Abstract] [Full Text] [Related]

  • 7. Pharmacokinetic difference between S-(+)- and R-(-)-etodolac in rats.
    Shi JM, Lai SG, Xu CJ, Duan GL, Li D.
    Acta Pharmacol Sin; 2004 Aug; 25(8):996-9. PubMed ID: 15301730
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetics of the antimalarial drug, AQ-13, in rats and cynomolgus macaques.
    Ramanathan-Girish S, Catz P, Creek MR, Wu B, Thomas D, Krogstad DJ, De D, Mirsalis JC, Green CE.
    Int J Toxicol; 2004 Aug; 23(3):179-89. PubMed ID: 15204721
    [Abstract] [Full Text] [Related]

  • 9. Enantiomeric disposition of ketorolac in goats following administration of a single intravenous and oral dose.
    Nagilla R, Deshmukh DD, Copedge KJ, Miller S, Martin B, Bell EC, Duran SH, Ravis WR.
    J Vet Pharmacol Ther; 2009 Feb; 32(1):49-55. PubMed ID: 19161455
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetics and bioavailability of nimesulide in goats.
    Rao GS, Malik JK, Siddaraju VB, Shankaramurthy NC.
    J Vet Pharmacol Ther; 2007 Apr; 30(2):157-62. PubMed ID: 17348902
    [Abstract] [Full Text] [Related]

  • 11. Pharmacokinetic study in man with the non-steroidal antiinflammatory drug flunoxaprofen. Serum concentration-time profile after oral or topical preparations.
    Bareggi SR, Pedrazzini S, De Angelis M.
    Arzneimittelforschung; 1988 Apr; 38(4):574-7. PubMed ID: 3401272
    [Abstract] [Full Text] [Related]

  • 12. Application of microdialysis for the determination of muscle and subcutaneous tissue concentrations after oral and topical ibuprofen administration.
    Tegeder I, Muth-Selbach U, Lötsch J, Rüsing G, Oelkers R, Brune K, Meller S, Kelm GR, Sörgel F, Geisslinger G.
    Clin Pharmacol Ther; 1999 Apr; 65(4):357-68. PubMed ID: 10223771
    [Abstract] [Full Text] [Related]

  • 13. Enhanced efficacy of triprolidine by transdermal application of the EVA matrix system in rabbits and rats.
    Shin SC, Choi JS.
    Eur J Pharm Biopharm; 2005 Sep; 61(1-2):14-9. PubMed ID: 16005195
    [Abstract] [Full Text] [Related]

  • 14. Stereoselective pharmacokinetics of ketorolac in calves after a single intravenous and oral dose.
    Nagilla R, Deshmukh DD, Duran SH, Ravis WR.
    J Vet Pharmacol Ther; 2007 Oct; 30(5):437-42. PubMed ID: 17803736
    [Abstract] [Full Text] [Related]

  • 15. Effects of oral dosing paradigms (gavage versus diet) on pharmacokinetics and pharmacodynamics.
    Kapetanovic IM, Krishnaraj R, Martin-Jimenez T, Yuan L, van Breemen RB, Lyubimov A.
    Chem Biol Interact; 2006 Dec 01; 164(1-2):68-75. PubMed ID: 17027946
    [Abstract] [Full Text] [Related]

  • 16. Bioavailability and pharmacokinetic studies of eurycomanone from Eurycoma longifolia.
    Low BS, Ng BH, Choy WP, Yuen KH, Chan KL.
    Planta Med; 2005 Sep 01; 71(9):803-7. PubMed ID: 16206032
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics of tramadol in rat plasma and cerebrospinal fluid after intranasal administration.
    Zhao Y, Tao T, Wu J, Pi J, He N, Chai X, Chen Q.
    J Pharm Pharmacol; 2008 Sep 01; 60(9):1149-54. PubMed ID: 18718117
    [Abstract] [Full Text] [Related]

  • 18. High-performance liquid chromatographic determination of oxatomide and its metabolite and its application to pharmacokinetic study in rat plasma.
    Kikuchi K, Ohishi T, Masuike T, Ohmori K, Sakai K.
    Arzneimittelforschung; 2002 Sep 01; 52(10):754-63. PubMed ID: 12442638
    [Abstract] [Full Text] [Related]

  • 19. Influence of cholestyramine on the pharmacokinetics of rosiglitazone and its metabolite, desmethylrosiglitazone, after oral and intravenous dosing of rosiglitazone: impact on oral bioavailability, absorption, and metabolic disposition in rats.
    Muzeeb S, Venkatesh P, Mullangi R, Srinivas NR.
    Xenobiotica; 2006 Sep 01; 36(9):838-56. PubMed ID: 16971347
    [Abstract] [Full Text] [Related]

  • 20. Kinetics of 3-(4-methylbenzylidene)camphor in rats and humans after dermal application.
    Schauer UM, Völkel W, Heusener A, Colnot T, Broschard TH, von Landenberg F, Dekant W.
    Toxicol Appl Pharmacol; 2006 Oct 15; 216(2):339-46. PubMed ID: 16814339
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.